E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/12/2012 in the Prospect News PIPE Daily.

Addex Therapeutics wraps CHF 9.64 million private placement of stock

Offering sells 918,025 of the company's shares at CHF 10.50 per share

By Devika Patel

Knoxville, Tenn., Oct. 12 - Addex Therapeutics said it raised CHF 9.64 million from a private placement of stock. Jefferies was the agent.

The company sold 918,025 ordinary shares at CHF 10.50 per share. The price per share is a 12.5% discount to the Oct. 11 closing share price of CHF 12.00.

The medical research company is based in Geneva.

Issuer:Addex Therapeutics
Issue:Ordinary shares
Amount:CHF 9,639,263
Shares:918,025
Price:CHF 10.50
Warrants:No
Agent:Jefferies
Settlement date:Oct. 12
Stock symbol:Switzerland: ADXN
Stock price:CHF 12.00 at close Oct. 11

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.